NICE backs first oral treatment to prevent chronic and episodic migraines Draft guidance from NICE backs the first oral treatment for prevention of chronic and episodic migraines in a move that could benefit around 170,000 people in England. by Nick Bostock Sign in to continue Sign In Email address Password Stay signed in Trouble signing in? Reset password: Click here Need help? Email us Register FREE Limited free articles a month Free email bulletins Register Now Register Now Take a 30-day trial Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days Sign Up Sign Up
